Literature DB >> 21107515

Cell cloning-based transcriptome analysis in cyclin-dependent kinase-like 5 mutation patients with severe epileptic encephalopathy.

Juliette Nectoux1, Yann Fichou, Nicolas Cagnard, Nadia Bahi-Buisson, Patrick Nusbaum, Franck Letourneur, Jamel Chelly, Thierry Bienvenu.   

Abstract

Mutations in the human CDKL5 gene have been shown to cause infantile spasms, as well as Rett syndrome-like phenotype. Because CDKL5 is subjected to X chromosome inactivation (XCI), individual cells from CDKL5 mutation girls either express the wild-type or mutant allele, likely resulting in different consequences at both the cellular and molecular levels. To identify these consequences, we carried out gene expression profiling on clonal populations derived from primary cultures of three patients' fibroblasts either expressing the wild-type or mutant allele. A total of 16 up-regulated and 20 down-regulated genes were identified. The differentially expressed gene products, mostly involved in differentiation and oxidative stress may be related to a mechanism underlying mental retardation and epilepsy. Among these, the apoptosis signal-regulated kinase MAP3K5 expression was found to be altered in non-neuronal, but also in neuronal CDKL5-deficient cells. Due to the fact that MAP3K5 activates MAP kinase pathway, which mediates signals leading to both differentiation and survival in neuronal cells, we suggest that a CDKL5 deficit may induce changes in synaptic plasticity in the patient's brain.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21107515     DOI: 10.1007/s00109-010-0699-x

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  27 in total

Review 1.  MAPK cascade signalling and synaptic plasticity.

Authors:  Gareth M Thomas; Richard L Huganir
Journal:  Nat Rev Neurosci       Date:  2004-03       Impact factor: 34.870

2.  Widespread monoallelic expression on human autosomes.

Authors:  Alexander Gimelbrant; John N Hutchinson; Benjamin R Thompson; Andrew Chess
Journal:  Science       Date:  2007-11-16       Impact factor: 47.728

3.  Periplakin interferes with G protein activation by the melanin-concentrating hormone receptor-1 by binding to the proximal segment of the receptor C-terminal tail.

Authors:  Hannah Murdoch; Gui-Jie Feng; Dietmar Bächner; Laura Ormiston; Julia H White; Dietmar Richter; Graeme Milligan
Journal:  J Biol Chem       Date:  2004-12-06       Impact factor: 5.157

4.  Apoptosis signal-regulating kinase 1 (ASK1) induces neuronal differentiation and survival of PC12 cells.

Authors:  K Takeda; T Hatai; T S Hamazaki; H Nishitoh; M Saitoh; H Ichijo
Journal:  J Biol Chem       Date:  2000-03-31       Impact factor: 5.157

5.  Mutations of CDKL5 cause a severe neurodevelopmental disorder with infantile spasms and mental retardation.

Authors:  Linda S Weaving; John Christodoulou; Sarah L Williamson; Kathie L Friend; Olivia L D McKenzie; Hayley Archer; Julie Evans; Angus Clarke; Gregory J Pelka; Patrick P L Tam; Catherine Watson; Hooshang Lahooti; Carolyn J Ellaway; Bruce Bennetts; Helen Leonard; Jozef Gécz
Journal:  Am J Hum Genet       Date:  2004-10-18       Impact factor: 11.025

6.  Mutations in the X-linked cyclin-dependent kinase-like 5 (CDKL5/STK9) gene are associated with severe neurodevelopmental retardation.

Authors:  Jiong Tao; Hilde Van Esch; M Hagedorn-Greiwe; Kirsten Hoffmann; Bettina Moser; Martine Raynaud; Jürgen Sperner; Jean-Pierre Fryns; Eberhard Schwinger; Jozef Gécz; Hans-Hilger Ropers; Vera M Kalscheuer
Journal:  Am J Hum Genet       Date:  2004-12       Impact factor: 11.025

7.  RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells.

Authors:  Jenn-Yah Yu; Stacy L DeRuiter; David L Turner
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-23       Impact factor: 11.205

8.  Epileptic encephalopathy in a girl with an interstitial deletion of Xp22 comprising promoter and exon 1 of the CDKL5 gene.

Authors:  Nadia Bahi-Buisson; Benoit Girard; Agnes Gautier; Juliette Nectoux; Yann Fichou; Yoann Saillour; Karine Poirier; Jamel Chelly; Thierry Bienvenu
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-01-05       Impact factor: 3.568

9.  CDKL5/Stk9 kinase inactivation is associated with neuronal developmental disorders.

Authors:  Clark Lin; Brunella Franco; Marsha Rich Rosner
Journal:  Hum Mol Genet       Date:  2005-12-05       Impact factor: 6.150

10.  Gene expression patterns vary in clonal cell cultures from Rett syndrome females with eight different MECP2 mutations.

Authors:  Jeff Traynor; Priyanka Agarwal; Laura Lazzeroni; Uta Francke
Journal:  BMC Med Genet       Date:  2002-11-05       Impact factor: 2.103

View more
  6 in total

Review 1.  Genetics, molecular biology, and phenotypes of x-linked epilepsy.

Authors:  Hao Deng; Wen Zheng; Zhi Song
Journal:  Mol Neurobiol       Date:  2013-11-22       Impact factor: 5.590

2.  CDKL5-Related Disorders: From Clinical Description to Molecular Genetics.

Authors:  N Bahi-Buisson; T Bienvenu
Journal:  Mol Syndromol       Date:  2011-09-13

3.  Angiotensin II facilitates breast cancer cell migration and metastasis.

Authors:  Sylvie Rodrigues-Ferreira; Mohamed Abdelkarim; Patricia Dillenburg-Pilla; Anny-Claude Luissint; Anne di-Tommaso; Frédérique Deshayes; Carmen Lucia S Pontes; Angie Molina; Nicolas Cagnard; Franck Letourneur; Marina Morel; Rosana I Reis; Dulce E Casarini; Benoit Terris; Pierre-Olivier Couraud; Claudio M Costa-Neto; Mélanie Di Benedetto; Clara Nahmias
Journal:  PLoS One       Date:  2012-04-20       Impact factor: 3.240

Review 4.  Recent advances in understanding synaptic abnormalities in Rett syndrome.

Authors:  Michael Johnston; Mary E Blue; Sakkubai Naidu
Journal:  F1000Res       Date:  2015-12-22

5.  CDKL5 promotes proliferation, migration, and chemotherapeutic drug resistance of glioma cells via activation of the PI3K/AKT signaling pathway.

Authors:  Zhenfu Jiang; Tongtong Gong; Hong Wei
Journal:  FEBS Open Bio       Date:  2020-01-21       Impact factor: 2.792

6.  GluD1 is a common altered player in neuronal differentiation from both MECP2-mutated and CDKL5-mutated iPS cells.

Authors:  Gabriella Livide; Tommaso Patriarchi; Mariangela Amenduni; Sonia Amabile; Dag Yasui; Eleonora Calcagno; Caterina Lo Rizzo; Giulia De Falco; Cristina Ulivieri; Francesca Ariani; Francesca Mari; Maria Antonietta Mencarelli; Johannes Wilhelm Hell; Alessandra Renieri; Ilaria Meloni
Journal:  Eur J Hum Genet       Date:  2014-06-11       Impact factor: 4.246

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.